Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. - Wikidata - awgldk - TriplyDB

Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells.

Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells.

http://www.wikidata.org/entity/Q35966957

about

Transcriptional Reactivation of the FMR1 Gene. A Possible Approach to the Treatment of the Fragile X Syndrome Human Embryonic Stem Cells: A Model for the Study of Neural Development and Neurological Diseases Human induced pluripotent stem cells for monogenic disease modelling and therapy Amniotic Fluid Stem Cells: A Novel Source for Modeling of Human Genetic Diseases hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine The Application of Human iPSCs in Neurological Diseases: From Bench to Bedside Induced pluripotent stem cells for modeling neurological disorders Understanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patients Using Patient-Derived Induced Pluripotent Stem Cells to Model and Treat Epilepsies Modeling neurodevelopmental disorders using human neurons iPSC-derived neurons as a higher-throughput readout for autism: promises and pitfalls Modelling human disease with pluripotent stem cells iPSCs and small molecules: a reciprocal effort towards better approaches for drug discovery Induced pluripotent stem cells as a disease modeling and drug screening platform Human pluripotent stem cells for modelling human liver diseases and cell therapy Modeling neurological disorders by human induced pluripotent stem cells Endothelial cells derived from nuclear reprogramming Using human induced pluripotent stem cells to treat retinal disease DNA repair in human pluripotent stem cells is distinct from that in non-pluripotent human cells A robust strategy for negative selection of Cre-loxP recombination-based excision of transgenes in induced pluripotent stem cells Modeling diseases of noncoding unstable repeat expansions using mutant pluripotent stem cells.Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine Ups and Downs: Mechanisms of Repeat Instability in the Fragile X-Related Disorders Modeling Fragile X Syndrome Using Human Pluripotent Stem Cells Utility of Induced Pluripotent Stem Cells for the Study and Treatment of Genetic Diseases: Focus on Childhood Neurological Disorders The Use of Induced Pluripotent Stem Cell Technology to Advance Autism Research and Treatment Induced Pluripotent Stem Cell Models to Enable In Vitro Models for Screening in the Central Nervous System Familial Dysautonomia (FD) Human Embryonic Stem Cell Derived PNS Neurons Reveal that Synaptic Vesicular and Neuronal Transport Genes Are Directly or Indirectly Affected by IKBKAP Downregulation Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells Stem cells and modeling of autism spectrum disorders.Modeling psychiatric disorders at the cellular and network levels Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives.Four decades of leading-edge research in the reproductive and developmental sciences: the Infant Primate Research Laboratory at the University of Washington National Primate Research Center.Estimating the quality of reprogrammed cells using ES cell differentiation expression patterns.Induced pluripotent stem cell: A headway in reprogramming with promising approach in regenerative biology Bio-collections in autism research.iPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.Female human iPSCs retain an inactive X chromosome.Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes.

P2860

Q26739927-B8341632-0AD7-4660-A2FA-5662E19A7568 Q26745433-C738D83E-58E1-4A90-A7C2-421391A43A80 Q26750393-8093271F-F761-4511-8A6C-FF81F427DF35 Q26750573-D815CD4D-D8FC-4DF6-96AC-EB2CF005F877 Q26751506-746FE6C4-4751-419A-BEBA-D6B7556B2320 Q26765876-4D1722A9-46A1-4191-A87E-642BCEBC0628 Q26771402-B8403B19-29B1-4067-8F8E-5C7C30FD6770 Q26784399-4ADDE09D-B4D4-46BD-9AF5-CC16C2D3B4BE Q26796332-D967DE09-3231-43BC-A29F-46234D435A6E Q26825057-40538B25-8ED3-4ADC-975D-70E7A4A3F3C0 Q26827249-E0321A2E-13B3-439C-87ED-C050E332088B Q26864380-75C8BCC5-514B-4A86-BFB4-623B5492B4E6 Q26865055-7323F883-0ED4-48D8-B4D9-D470E683720A Q26865689-6D8232E0-EA9E-4607-B7C8-31B8D63038FF Q27005360-F62212CD-D025-4955-B5A1-25055DB70E31 Q27011777-20CC802E-90E6-46FC-9263-149BA3464B78 Q27011837-3EE13E46-1E8A-4E6D-AED5-7E42C1E4FBBE Q27015087-7EFF867C-1E15-45B2-A5C2-0EB306CDBE8F Q27309692-7FD1879D-E4F9-488C-B280-A3114673E47E Q27318778-1014D832-582B-4356-BC41-6028C67757BF Q27687330-91E787CB-28A5-489B-B3F0-4C5E76D01A58 Q28076397-305183B0-44C3-482E-AA18-4D3EF2E0F588 Q28079925-2ADDFF62-7102-4C00-822E-E7E04CD5BBC3 Q28080022-B4A029DF-755B-4088-BD54-DB26741257A9 Q28080219-AB631F77-BE22-4C32-AA56-DCE6B0A05BDF Q28081659-D30A0FC9-6155-4721-8D94-E59746BCDB88 Q28082668-43F6308E-3916-4EDC-9089-082BABB4CCF7 Q28550043-7BA27F5E-12C0-4DD0-8C6F-0A719E8BE268 Q29615870-1801681F-0DED-4BF6-8989-814FDC7E7A68 Q30401824-A7886C36-4551-4CC5-973E-03C27254F56A Q30446669-9CC544E1-BB09-4F5B-BB5B-DCEFDBDD867E Q33659830-C292B3C1-4D7D-4077-BF76-7406DEBD0689 Q33750568-EBDCAB7B-0A36-42F5-8390-B48CFC7B8A98 Q33808522-4F83F553-CB3A-4DBD-ACE9-696B1B8A0198 Q33877155-C61EC5D6-727E-433A-BDD4-DB3F6A498318 Q33892169-DF81A3DD-35E6-4204-AD1B-DC9328D0FA9D Q33919340-AD53250F-4173-48A7-91BE-28E43C2621E1 Q34056154-EF27A266-2754-47B6-A1F8-F53D82A2511C Q34111572-B377F65E-9E7F-41C7-99CB-B7525DB88A91 Q34140440-582DB8A6-CA84-42B4-A43F-71BD91EDDB55

P2860

Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells.

http://www.wikidata.org/entity/Q35966957

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Differential modeling of fragi ...... nduced pluripotent stem cells.

@ast

Differential modeling of fragi ...... nduced pluripotent stem cells.

@en

type

label

Differential modeling of fragi ...... nduced pluripotent stem cells.

@ast

Differential modeling of fragi ...... nduced pluripotent stem cells.

@en

altLabel

Differential modeling of fragi ...... induced pluripotent stem cells

@en

prefLabel

Differential modeling of fragi ...... nduced pluripotent stem cells.

@ast

Differential modeling of fragi ...... nduced pluripotent stem cells.

@en

P1433

Q35966957-040FE182-80F1-475A-992C-464CBA880F0C

P1476

Q35966957-7CFE9585-D15C-4644-8CA9-34D1F8EE2C95

P2093

Q35966957-6DCB2D05-A7AA-4EEB-AB8F-C87DAEA16C37

Q35966957-FEC98008-58C7-4D51-9BA9-0BC5A9DE809D

P2860

Q35966957-021A74D3-2224-44C6-B25C-C0E9FAD05D3F

Q35966957-06AF5ACB-381C-4193-A4A3-C24842F1077C

Q35966957-088158C5-FC53-4E7D-98F4-1E96B4E0DD6F

Q35966957-0C8C712F-CE80-4727-ACF4-DBE0587E0B67

Q35966957-0F202E1C-FCFA-4132-A266-2FBED12A3E1B

Q35966957-1264B9F0-1C49-4CFE-BE5B-94DE8C64F85D

Q35966957-1328D0C5-FA4F-469A-BDE7-EE621DFB99B8

Q35966957-1B463EBB-753E-4E73-934F-BACB53A44C25

Q35966957-1E25CA54-F4F3-48AA-BE2E-A5BE2648312A

Q35966957-37A8785C-307C-431F-BE9C-1A983501BFD8

P304

Q35966957-E12F1CD1-8D15-4609-BB72-87914C291246

P31

Q35966957-FB17FD8A-E7B4-4918-BC06-4DC8A8EC7F25

P356

Q35966957-1FFA4B20-8CB0-4752-AFB1-80B0CA95F659

P407

Q35966957-01F35FD5-0827-4BBA-BDF0-9072C9B1E9D3

P433

Q35966957-55F6FF3F-1EE9-49D4-9641-7DD6B254580C

P478

Q35966957-C418A817-3DB5-439E-8E72-8FA1FDD94D2D

P50

Q35966957-181555AC-DD0B-448B-BBAE-D045C6ECC8B5

Q35966957-977F1FF4-82E5-46E3-8EDF-1AB38EF60947

P577

Q35966957-EEE7B5FD-6E55-4993-A230-BDD186E4D5A1

P5875

Q35966957-B1D05634-E66D-4169-BD5E-C049E9C581BA

P698

Q35966957-7AD64E59-3D62-400A-8070-0E1B3C18A710

P921

Q35966957-7A97AAA2-7D54-4140-B0AD-ED9A9F3109D2

P932

Q35966957-047AA1C0-2FA6-4F99-B57A-966CA2337E77

P356

J.STEM.2010.04.005

P1433

P1476

Differential modeling of fragi ...... nduced pluripotent stem cells.

@en

P2093

Achia Urbach

http://www.w3.org/2001/XMLSchema#string

Ori Bar-Nur

http://www.w3.org/2001/XMLSchema#string

P2860

Disease-specific induced pluripotent stem cells

Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing

Induced pluripotent stem cell lines derived from human somatic cells

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Embryonic stem cell lines derived from human blastocysts

A decade of molecular studies of fragile X syndrome

Reprogramming of human somatic cells to pluripotency with defined factors

Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome

Rapid and quantitative method of allele-specific DNA methylation analysis

Demethylation, reactivation, and destabilization of human fragile X full-mutation alleles in mouse embryocarcinoma cells.

P304

407-411

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.STEM.2010.04.005

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

George Q. Daley

Nissim Benvenisty

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44582398

http://www.w3.org/2001/XMLSchema#string

P698

20452313

http://www.w3.org/2001/XMLSchema#string

P921

Human Induced Pluripotent Stem Cells

P932

3354574

http://www.w3.org/2001/XMLSchema#string